OneMedNet Corporation (ONMD)
| Previous Close | 0.5740 |
| Open | 0.5623 |
| Bid | 0.5557 x 100 |
| Ask | 0.6263 x 100 |
| Day's Range | 0.5623 - 0.6000 |
| 52 Week Range | 0.4200 - 13.5100 |
| Volume | |
| Avg. Volume | 832,062 |
| Market Cap | 14.279M |
| Beta (5Y Monthly) | -0.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Newsfile
OneMedNet Corporation Announces Participation in the EF Hutton Annual Global Conference
Minneapolis, Minnesota--(Newsfile Corp. - May 2, 2024) - OneMedNet Corporation (NASDAQ: ONMD), is the leading curator of precision curated regulatory-grade Real World Data (“RWD”), will be participating in the EF Hutton Annual Global Conference, which will take place on May 15, 2024 at The Plaza Hotel in New York. Aaron Green, President & CEO and Dr. Jeffrey Yu, Founder & CMO, will be presenting on May 15th. Interested parties can ...
GlobeNewswireOneMedNet Joins ClinEco Community of Clinical Research Industry Members
~ Validates OneMedNet’s Regulatory Grade Real World Data Platform Among the Clinical Trial Eco-System ~ MINNEAPOLIS, April 30, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet”), the leading curator of precision curated regulatory-grade Real World Data (“RWD”), today announced that it has accepted an invitation to join ClinEco Inc., a connectivity platform and community environment, which improves access and expands distribution while promoting streamlined partner intera
GlobeNewswireOneMedNet Completes Securities Purchase Agreement, Solidifying Cash Position to Accelerate Growth
Cash Infusion Provides Significant Cash Runway of Up to $4.54 MillionMINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade Real World Data (“iRWD™”), through its proven OneMedNet iRWD™ solution, today announced that it has entered into a definitive securities purchase agreement (the “Securities Purchase Agreement“) dated as of March 28, 2024 with an institutional investor (the “Investor“) provi
